To sign up for our newsletter or print publications, please enter your contact information below.
Dana-Farber Cancer Institute, Boston, Massachusetts
Two-pronged attack on chemotherapy-resistant leukemia cells
An Early Look at Research From the 2016 ASCO Annual Meeting
Drug against breast cancer is also highly potent against a frequent form of leukaemia
Improving natural killer cancer therapy: Study